Registered Malawi · PMRA

EPHERINE 0.5% NASAL DROPS

EPHERINE

PMPB/PL125/12 NASAL DROPS

What it does

Ephedrine is a medication used to treat certain conditions related to breathing and to raise blood pressure when it is too low.

Commonly used for: asthma, bronchospasm, low blood pressure (hypotension)

Read more in plain English ↓

Plain-language summary for general understanding - not medical advice. Always follow your pharmacist/doctor.

Ask about this medicine

Answers come only from this medicine's registration record, BNF monograph and interaction data - not medical advice.

Medicine sourcing is available in Kenya only. We don't sell or dispense medicines - licensed pharmacies do.

Sourcing - Kenya only

Registration & product details

Registration no.
PMPB/PL125/12
Registration date
09/03/2001
Expiry date
28/02/2003
Status
Registered
Active ingredient
EPHERINE
Dosage form
NASAL DROPS
Strength
-
Pack size
-
Therapeutic class
-
Manufacturer / MAH
-
Applicant / LTR
-
Country of origin
-

Source: Pharmacy and Medicines Regulatory Authority · fetched 2026-04-21 17:37:38 · updated 2026-09-19 04:30:22

Disclaimer: This information is sourced from Pharmacy and Medicines Regulatory Authority (Malawi). Always consult a qualified healthcare professional before using any medication.

About this medicine

Ephedrine is a medication used to treat certain conditions related to breathing and to raise blood pressure when it is too low.

What it treats

  • asthma
  • bronchospasm
  • low blood pressure (hypotension)

How it works

Ephedrine works by stimulating the heart and opening the airways, making it easier to breathe and helping to increase blood flow.

Who it's for

This medication is for patients who have breathing difficulties or low blood pressure.

AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.

Clinical monograph: epherine

Ephedrine is a sympathomimetic amine that acts primarily as a bronchodilator and a respiratory stimulant. It is commonly used to treat conditions such as asthma and bronchospasm, as well as for its vasopressor effects in hypotensive states. Ephedrine stimulates the adrenergic receptors, leading to various physiological effects including increased heart rate, bronchodilation, and increased blood pressure.

Indications

  • Asthma
  • Bronchospasm
  • Hypotension
  • Nasal congestion

Dosage

Children: Refer to BNF for Children for appropriate dosing. Pediatric doses are typically weight-based and should be calculated carefully.

Adults: Refer to specific guidelines or BNF resources for appropriate dosing. Typical adult doses vary based on condition and route of administration.

Mechanism of action

Ephedrine acts as a nonselective agonist of adrenergic receptors, particularly beta-2 adrenergic receptors in the lungs, leading to bronchodilation. It also stimulates alpha-adrenergic receptors, which causes vasoconstriction and increased blood pressure. Additionally, ephedrine has indirect sympathomimetic effects by promoting the release of norepinephrine from sympathetic nerve endings.

Pharmacodynamics

Ephedrine's primary pharmacodynamic effects include increased bronchial smooth muscle relaxation, enhanced cardiac output, and vasoconstriction. It increases the release of catecholamines, which further amplifies its effects on heart rate and blood pressure. The onset of action can be rapid, with peak effects occurring within 1-2 hours, depending on the route of administration.

Pharmacokinetics

Ephedrine is well absorbed following oral administration, with bioavailability around 30-90%. It is metabolized mainly by the liver and has a half-life of approximately 3-6 hours. The drug is excreted primarily in the urine, with renal clearance being an important factor in its elimination. The pharmacokinetics can be influenced by factors such as pH and urinary flow rates.

Contra-indications

  • Severe hypertension
  • Severe coronary artery disease
  • Hyperthyroidism
  • Pheochromocytoma
  • History of hypersensitivity to ephedrine or other sympathomimetics

Adverse effects

  • Insomnia
  • Nervousness
  • Dizziness
  • Palpitations
  • Tachycardia
  • Hypertension
  • Nausea
  • Vomiting
  • Headache
  • Dry mouth

Interactions

  • Monoamine oxidase inhibitors (MAOIs) may enhance the effects of ephedrine
  • Other sympathomimetics may increase the risk of cardiovascular side effects
  • Antihypertensives may have reduced efficacy
  • Caffeine may increase the stimulant effects

Precautions

  • Use with caution in patients with cardiovascular disorders
  • Monitor blood pressure and heart rate regularly
  • May exacerbate pre-existing conditions such as diabetes or hyperthyroidism
  • Caution in the elderly due to increased sensitivity to sympathomimetics

Pregnancy

Ephedrine is classified as category C. Its use should be avoided unless the potential benefits outweigh the risks.

Breast-feeding

Ephedrine is excreted in breast milk. Caution is advised when administering to nursing mothers.

Storage

Store in a cool, dry place away from light. Keep out of reach of children.

Formulations

  • Oral tablets
  • Injectable solution
  • Syrup

AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.